uniQure N.V. (NASDAQ: QURE) Stock Information | RedChip

uniQure N.V. (NASDAQ: QURE)


$6.0100
+0.2300 ( +2.39% ) 233.7K

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Market Data


Open


$6.0100

Previous close


$5.7800

Volume


233.7K

Market cap


$301.72M

Day range


$5.7800 - $6.2350

52 week range


$3.7300 - $11.3500

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 17, 2024
8-k 8K-related 15 Jun 03, 2024
10-q Quarterly Reports 62 May 07, 2024
8-k 8K-related 15 May 07, 2024
ars Annual reports 1 May 01, 2024
def Proxies and info statements 20 Apr 24, 2024
pre Proxies and info statements 21 Apr 12, 2024
8-k 8K-related 13 Apr 12, 2024
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Mar 05, 2024

Latest News